Literature DB >> 11475339

Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine.

E A Lee1, J H Oh, H A Lee, S I Kim, E W Park, K B Park, M S Park.   

Abstract

OBJECTIVE: The effect of long-term use of high glucose dialysate on peritoneal structure and function, and its relation with accumulation of advanced glycosylation end-product (AGE) in the peritoneum was investigated in this study.
METHODS: Dialysates with 4.25% glucose were injected into the peritoneal cavity of normal rats for 12 weeks without (PD, n = 7) and with (1 g/L, PD+AG, n = 7) aminoguanidine in their drinking water. Rats not having intraperitoneal (IP) injection served as control (n = 9). After 12 weeks of IP injection, a 2-hour peritoneal equilibration test (PET) was performed using 30 mL 4.25% glucose dialysate. Intraperitoneal volume (IPV), dialysate-to-plasma urea ratio at 2 hours (D/P2), the ratio of dialysate glucose at 2 hours to initial dialysate glucose (D2/D0), and the peritoneal fluid absorption rate (Qa) were evaluated. After the PET, samples of the parietal peritoneum were taken for hematoxylin and eosin (H&E) staining and immunohistochemical staining for AGE.
RESULTS: The IPV and D2/D0 glucose were significantly lower and Qa and D2/P2 urea significantly higher in the PD group than in the control group. Aminoguanidine reversed in part the changes in IPV and D2/P2 urea in the PD group; it had no effect on Qa and D2/D0 glucose. The H&E staining showed a linear mesothelial lining with negligible cells and capillaries in the narrow submesothelial space in the control group. Mesothelial denudation and submesothelial infiltration of monocytes and capillary formation were observed in the PD group. Mesothelial denudation was relatively intact in the PD+AG group compared with the PD group. Submesothelial monocyte infiltration and capillary formation in the PD+AG group were not as prominent as in the PD group. Positive AGE staining was found in the submesothelial space, vascular walls, and endomysium in the PD group, while it was markedly attenuated in PD+AG group and negligible in the control group.
CONCLUSION: Long-term use of high glucose solutions induced peritoneal AGE accumulation and mesothelial denudation, and increased peritoneal permeability and peritoneal fluid absorption rate. Inhibition of peritoneal AGE accumulation prevented those functional and structural damages to the peritoneum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475339

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

2.  Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer.

Authors:  Ken-ichi Kaneda; Keiichi Miyamoto; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

Review 3.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

4.  Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.

Authors:  Nobuhiro Ayuzawa; Yoshitaka Ishibashi; Yutaka Takazawa; Haruki Kume; Toshiro Fujita
Journal:  Perit Dial Int       Date:  2011-07-31       Impact factor: 1.756

Review 5.  Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.

Authors:  Sandeep K Mallipattu; John C He; Jaime Uribarri
Journal:  Semin Dial       Date:  2012-04-30       Impact factor: 3.455

Review 6.  Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

Authors:  Sandeep K Mallipattu; Jaime Uribarri
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

7.  Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Margot N Schilte; Piet M Ter Wee; Robert H J Beelen
Journal:  Int J Nephrol       Date:  2011-08-02

Review 8.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

9.  The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium.

Authors:  Yong-Kook Lee; Joon-Yeop Lee; Jun-Seup Kim; Ki-Bum Won; Hyeok-Joo Kang; Tae-Jung Jang; Woo-Taek Tak; Jeong-Ho Lee
Journal:  J Korean Med Sci       Date:  2009-01-29       Impact factor: 2.153

10.  Retinoic acid improves morphology of cultured peritoneal mesothelial cells from patients undergoing dialysis.

Authors:  Carmen Retana; Elsa I Sanchez; Sirenia Gonzalez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas-Munoz; Carmen Alfaro-Cruz; Socorro Vital-Flores; José L Reyes
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.